|
1
|
Chen W: Cancer statistics: Updated cancer
burden in China. Chin J Cancer Res. 27:12015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tarraga Lopez PJ, Albero JS and
Rodriguez-Montes JA: Primary and secondary prevention of colorectal
cancer. Clin Med Insights Gastroenterol. 7:33–46. 2014.PubMed/NCBI
|
|
3
|
Center MM, Jemal A and Ward E:
International trends in colorectal cancer incidence rates. Cancer
Epidemiol Biomarkers Prev. 18:1688–1694. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ferrari P, Jenab M, Norat T, Moskal A,
Slimani N, Olsen A, Tjonneland A, Overvad K, Jensen MK,
Boutron-Ruault MC, et al: Lifetime and baseline alcohol intake and
risk of colon and rectal cancers in the European prospective
investigation into cancer and nutrition (EPIC). Int J Cancer.
121:2065–2072. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hooker CM, Gallicchio L, Genkinger JM,
Comstock GW and Alberg AJ: A prospective cohort study of rectal
cancer risk in relation to active cigarette smoking and passive
smoke exposure. Ann Epidemiol. 18:28–35. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zoratto F, Rossi L, Verrico M, Papa A,
Basso E, Zullo A, Tomao L, Romiti A, Lo Russo G and Tomao S: Focus
on genetic and epigenetic events of colorectal cancer pathogenesis:
Implications for molecular diagnosis. Tumour Biol. 35:6195–6206.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Brenner H, Kloor M and Pox CP: Colorectal
cancer. Lancet. 383:1490–1502. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huang G, Chen X, Cai Y, Wang X and Xing C:
miR-20a-directed regulation of BID is associated with the TRAIL
sensitivity in colorectal cancer. Oncol Rep. 37:571–578. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gulyaeva LF and Kushlinskiy NE: Regulatory
mechanisms of microRNA expression. J Transl Med. 14:1432016.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ryan BM: microRNAs in cancer
susceptibility. Adv Cancer Res. 135:151–171. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yang W, Ma J, Zhou W, Cao B, Zhou X, Zhang
H, Zhao Q, Hong L and Fan D: Reciprocal regulations between miRNAs
and HIF-1α in human cancers. Cell Mol Life Sci. 76:453–471. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang B: MicroRNA: A new target for
improving plant tolerance to abiotic stress. J Exp Bot.
66:1749–1761. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lin C, Gao B, Yan X, Lei Z, Chen K, Li Y,
Zeng Q, Chen Z and Li H: MicroRNA 628 suppresses migration and
invasion of breast cancer stem cells through targeting SOS1. Onco
Targets Ther. 11:5419–5428. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen L, Jiang X, Chen H, Han Q, Liu C and
Sun M: microRNA-628 inhibits the proliferation of acute myeloid
leukemia cells by directly targeting IGF-1R. Onco Targets Ther.
12:907–919. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ichihara A and Tanaka K: Roles of
proteasomes in cell growth. Mol Biol Rep. 21:49–52. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yuan C, Zhu X, Han Y, Song C, Liu C, Lu S,
Zhang M, Yu F, Peng Z and Zhou C: Elevated HOXA1 expression
correlates with accelerated tumor cell proliferation and poor
prognosis in gastric cancer partly via cyclin D1. J Exp Clin Cancer
Res. 35:152016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Li Y, Shen L, Xu H, Pang Y, Xu Y, Ling M,
Zhou J, Wang X and Liu Q: Up-regulation of cyclin D1 by JNK1/c-Jun
is involved in tumorigenesis of human embryo lung fibroblast cells
induced by a low concentration of arsenite. Toxicol Lett.
206:113–120. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Z, Wang Y, Wang S, Meng X, Song F,
Huo W, Zhang S, Chang J, Li J, Zheng B, et al: Coxsackievirus A6
induces cell cycle arrest in G0/G1 phase for viral production.
Front Cell Infect Microbiol. 8:2792018. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Por E, Byun HJ, Lee EJ, Lim JH, Jung SY,
Park I, Kim YM, Jeoung DI and Lee H: The cancer/testis antigen CAGE
with oncogenic potential stimulates cell proliferation by
up-regulating cyclins D1 and E in an AP-1- and E2F-dependent
manner. J Biol Chem. 285:14475–14485. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen JY, Lin JR, Tsai FC and Meyer T:
Dosage of Dyrk1a shifts cells within a p21-cyclin D1 signaling map
to control the decision to enter the cell cycle. Mol Cell.
52:87–100. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Xie M, Zhao F, Zou X, Jin S and Xiong S:
The association between CCND1 G870A polymorphism and colorectal
cancer risk: A meta-analysis. Medicine (Baltimore). 96:e82692017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen Z, Chen X, Xie R, Huang M, Dong W,
Han J, Zhang J, Zhou Q, Li H, Huang J and Lin T: DANCR promotes
metastasis and proliferation in bladder cancer cells by enhancing
IL-11-STAT3 signaling and CCND1 expression. Mol Ther. 27:326–341.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Portari EA, Russomano FB, de Camargo MJ,
Machado Gayer CR, da Rocha Guillobel HC, Santos-Reboucas CB and
Brito Macedo JM: Immunohistochemical expression of cyclin D1,
p16Ink4a, p21WAF1, and Ki-67 correlates with the severity of
cervical neoplasia. Int J Gynecol Pathol. 32:501–508. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jiang D, Li H, Xiang H, Gao M, Yin C, Wang
H, Sun Y and Xiong M: Long Chain non-coding RNA (lncRNA) HOTAIR
knockdown increases miR-454-3p to suppress gastric cancer growth by
targeting STAT3/Cyclin D1. Med Sci Monit. 25:1537–1548. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dai M, Al-Odaini AA, Fils-Aime N,
Villatoro MA, Guo J, Arakelian A, Rabbani SA, Ali S and Lebrun JJ:
Cyclin D1 cooperates with p21 to regulate TGFβ-mediated breast
cancer cell migration and tumor local invasion. Breast Cancer Res.
15:R492013. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tong WW, Tong GH, Chen XX, Zheng HC and
Wang YZ: HIF2α is associated with poor prognosis and affects the
expression levels of survivin and cyclin D1 in gastric carcinoma.
Int J Oncol. 46:233–242. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Huang YS, Jie N, Zhang YX, Zou KJ and Weng
Y: shRNA-induced silencing of Ras-related C3 botulinum toxin
substrate 1 inhibits the proliferation of colon cancer cells
through upregulation of BAD and downregulation of cyclin D1. Int J
Mol Med. 41:1397–1408. 2018.PubMed/NCBI
|
|
28
|
Al-Qasem A, Al-Howail HA, Al-Swailem M,
Al-Mazrou A, Al-Otaibi B, Al-Jammaz I, Al-Khalaf HH and Aboussekhra
A: PAC exhibits potent anti-colon cancer properties through
targeting cyclin D1 and suppressing epithelial-to-mesenchymal
transition. Mol Carcinog. 55:233–244. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nie J, Liu L, Zheng W, Chen L, Wu X, Xu Y,
Du X and Han W: microRNA-365, down-regulated in colon cancer,
inhibits cell cycle progression and promotes apoptosis of colon
cancer cells by probably targeting Cyclin D1 and Bcl-2.
Carcinogenesis. 33:220–225. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Park SB, Park GH, Song HM, Son HJ, Um Y,
Kim HS and Jeong JB: Anticancer activity of calyx of Diospyros kaki
Thunb. Through downregulation of cyclin D1 via inducing proteasomal
degradation and transcriptional inhibition in human colorectal
cancer cells. BMC Complement Altern Med. 17:4452017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Huang R, Lin JY and Chi YJ: miR-519d
reduces the 5-fluorouracil resistance in colorectal cancer cells by
down-regulating the expression of CCND1. Eur Rev Med Pharmacol Sci.
22:2869–2875. 2018.PubMed/NCBI
|
|
32
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Arvelo F, Sojo F and Cotte C: Biology of
colorectal cancer. Ecancermedicalscience. 9:5202015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Asano H, Kojima K, Ogino N, Fukano H,
Ohara Y and Shinozuka N: Postoperative recurrence and risk factors
of colorectal cancer perforation. Int J Colorectal Dis. 32:419–424.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Huang Z, Huang S, Wang Q, Liang L, Ni S,
Wang L, Sheng W, He X and Du X: MicroRNA-95 promotes cell
proliferation and targets sorting Nexin 1 in human colorectal
carcinoma. Cancer Res. 71:2582–2589. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Sayed D, Rane S, Lypowy J, He M, Chen IY,
Vashistha H, Yan L, Malhotra A, Vatner D and Abdellatif M:
MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. Mol
Biol Cell. 19:3272–3282. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Jin W, Shi J and Liu M: Overexpression of
miR-671-5p indicates a poor prognosis in colon cancer and
accelerates proliferation, migration, and invasion of colon cancer
cells. Onco Targets Ther. 12:6865–6873. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Weng L, Ma J, Jia YP, Wu SQ, Liu BY, Cao
Y, Yin X, Shang MY and Mao AW: miR-4262 promotes cell apoptosis and
inhibits proliferation of colon cancer cells: Involvement of
GALNT4. Am J Transl Res. 10:3969–3977. 2018.PubMed/NCBI
|
|
41
|
Wang Q, Huang Z, Guo W, Ni S, Xiao X, Wang
L, Huang D, Tan C, Xu Q, Zha R, et al: microRNA-202-3p inhibits
cell proliferation by targeting ADP-ribosylation factor-like 5A in
human colorectal carcinoma. Clin Cancer Res. 20:1146–1157. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sheng S, Xie L, Wu Y, Ding M, Zhang T and
Wang X: miR-144 inhibits growth and metastasis in colon cancer by
down-regulating SMAD4. Biosci Rep. 39(pii): BSR201818952019.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Guo L, Fu J, Sun S, Zhu M, Zhang L, Niu H,
Chen Z, Zhang Y, Guo L and Wang S: MicroRNA-143-3p inhibits
colorectal cancer metastases by targeting ITGA6 and ASAP3. Cancer
Sci. 110:805–816. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li M, Qian Z, Ma X, Lin X, You Y, Li Y,
Chen T and Jiang H: miR-628-5p decreases the tumorigenicity of
epithelial ovarian cancer cells by targeting at FGFR2. Biochem
Biophys Res Commun. 495:2085–2091. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Jiang M, Zhou LY, Xu N and An Q:
Down-regulation of miR-500 and miR-628 suppress non-small cell lung
cancer proliferation, migration and invasion by targeting ING1.
Biomed Pharmacother. 108:1628–1639. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Yao Y, Luo J, Sun Q, Xu T, Sun S, Chen M,
Lin X, Qian Q, Zhang Y, Cao L, et al: HOXC13 promotes proliferation
of lung adenocarcinoma via modulation of CCND1 and CCNE1. Am J
Cancer Res. 7:1820–1834. 2017.PubMed/NCBI
|
|
47
|
Chen DG, Zhu B, Lv SQ, Zhu H, Tang J,
Huang C, Li Q, Zhou P, Wang DL and Li GH: Inhibition of EGR1
inhibits glioma proliferation by targeting CCND1 promoter. J Exp
Clin Cancer Res. 36:1862017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Xue J, Qin Z, Li X, Zhang J, Zheng Y, Xu
W, Cao Q and Wang Z: Genetic polymorphisms in cyclin D1 are
associated with risk of renal cell cancer in the Chinese
population. Oncotarget. 8:80889–80899. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Chen Y, Jiang J, Zhao M, Luo X, Liang Z,
Zhen Y, Fu Q, Deng X, Lin X, Li L, et al: microRNA-374a suppresses
colon cancer progression by directly reducing CCND1 to inactivate
the PI3K/AKT pathway. Oncotarget. 7:41306–41319. 2016.PubMed/NCBI
|
|
50
|
Lee Y, Ko D, Min HJ, Kim SB, Ahn HM, Lee Y
and Kim S: TMPRSS4 induces invasion and proliferation of prostate
cancer cells through induction of Slug and cyclin D1. Oncotarget.
7:50315–50332. 2016.PubMed/NCBI
|
|
51
|
Melling N, Kowitz CM, Simon R, Bokemeyer
C, Terracciano L, Sauter G, Izbicki JR and Marx AH: High Ki67
expression is an independent good prognostic marker in colorectal
cancer. J Clin Pathol. 69:209–214. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
de Azambuja E, Cardoso F, de Castro G Jr,
Colozza M, Mano MS, Durbecq V, Sotiriou C, Larsimont D,
Piccart-Gebhart MJ and Paesmans M: Ki-67 as prognostic marker in
early breast cancer: A meta-analysis of published studies involving
12,155 patients. Br J Cancer. 96:1504–1513. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Pollack A, DeSilvio M, Khor LY, Li R,
Al-Saleem TI, Hammond ME, Venkatesan V, Lawton CA, Roach M III,
Shipley WU, et al: Ki-67 staining is a strong predictor of distant
metastasis and mortality for men with prostate cancer treated with
radiotherapy plus androgen deprivation: Radiation Therapy Oncology
Group Trial 92-02. J Clin Oncol. 22:2133–2140. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Hassan M, Watari H, AbuAlmaaty A, Ohba Y
and Sakuragi N: Apoptosis and molecular targeting therapy in
cancer. Biomed Res Int. 2014:1508452014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Weng C, Li Y, Xu D, Shi Y and Tang H:
Specific cleavage of Mcl-1 by caspase-3 in tumor necrosis
factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis
in Jurkat leukemia T cells. J Biol Chem. 280:10491–10500. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Porter AG and Janicke RU: Emerging roles
of caspase-3 in apoptosis. Cell Death Differ. 6:99–104. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Du J, Leng J, Zhang L, Bai G, Yang D, Lin
H and Qin J: Angiotensin II-induced apoptosis of human umbilical
vein endothelial cells was inhibited by blueberry anthocyanin
through Bax- and caspase 3-dependent pathways. Med Sci Moni.
22:3223–3228. 2016. View Article : Google Scholar
|
